203 results on '"A. Lievre"'
Search Results
2. Dystrophin deficiency impairs cell junction formation during embryonic myogenesis from pluripotent stem cells
3. Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France
4. Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from France
5. Biliary tract cancers: French national clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACABi, ACHBPT)
6. Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies
7. Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer
8. Prognostic score for synchronous metastatic rectal cancer: A real-world study
9. On the variants of SVM method for the estimation of soil elastic modulus from TSD model: Numerical parametric study
10. Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trial
11. From a spontaneous community of practice to a piloted community of practice: A longitudinal study of resilience construction
12. Classification of PRSS1 variants responsible for chronic pancreatitis: An expert perspective from the Franco-Chinese GREPAN Study Group
13. Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE
14. Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?
15. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
16. Systematic review of randomised clinical trials and observational studies for patients with RAS wild-type or BRAFV600E-mutant metastatic and/or unresectable colorectal cancer
17. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process
18. Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial
19. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
20. Decision-making training in sporting officials: Past, present and future
21. Cost-Utility Analysis of Transarterial Radioembolization With Yttrium-90 Resin Microspheres Compared With Sorafenib in Locally Advanced and Inoperable Hepatocellular Carcinoma
22. What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort
23. Vaccination contre la COVID-19 des patients atteints de cancer solide : revue et préconisations d’un inter-groupe oncologique français (CGO, TNCD, UNICANCER)
24. PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer
25. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
26. Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)
27. Autoimmune cerebellar hypermetabolism: Report of three cases and literature overview
28. Atteinte cérébelleuse d’origine auto-immune : à propos de deux cas avec hypermétabolisme cérébelleux
29. Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27)
30. Place of anti-EGFR therapy in older patients with metastatic colorectal cancer in 2020
31. Improving the screening of precancerous anal lesions in high-risk subjects with normal cytology: A longitudinal cohort study using simple tests
32. Maintenance treatment with fluoropyrimidine plus bevacizumab versus fluoropyrimidine alone after induction chemotherapy for metastatic colorectal cancer: The BEVAMAINT - PRODIGE 71 - (FFCD 1710) phase III study
33. Cancers colorectaux avec mutation V600E de BRAF : où en sommes-nous ?
34. Management of T1 colorectal cancers detected at screening colonoscopy: A study from the French national screening programme
35. COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)
36. The assistant referees’ activity in refereeing elite football: Preoccupations when not judging offside
37. Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II study
38. An analysis of soccer referee experiences in France and the Netherlands: Abuse, conflict, and level of support
39. Access to the waiting list and to kidney transplantation for people living with HIV: A national registry study
40. A study of the individual activity of professional volleyball players: Situation assessment and sensemaking under time pressure
41. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening
42. Sustainably reconciling offshore renewable energy with Natura 2000 sites: An interim adaptive management framework
43. Apport de l'immunothérapie dans le traitement des cancers des voies biliaires avancés
44. État des lieux des pratiques de prise en charge des cancers des voies biliaires en France : résultats de l'enquête nationale ACABi
45. RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014
46. Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41–BEVANEC randomized phase II study
47. Transcriptomic approach: A promising tool for rapid screening nanomaterial-mediated toxicity in the marine bivalve Mytilus edulis—Application to copper oxide nanoparticles
48. La co-production de la performance arbitrale de haut niveau : le cas du rugby
49. Représentativité de Der p 23 dans les Produits Allergènes Dermatophagoides pteronyssinus, produits en France
50. Fecal immunological blood test is more appealing than the guaiac-based test for colorectal cancer screening
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.